Dr Lalchandani Labs Ltd
Ticker: DLCL
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
22.49
Market Cap
9.84
Debt/Equity
0.4090
ROE %
4.207
PB
0.9890
Promoter %
48.322
Pledge %
0.000
1Y Rev Growth %
-26.603
5Y Rev Growth %
-5.571
NP Margin %
8.952
NP Margin 5Y Avg %
1.316
Trading Reference
1M Return %
-7.143
6M Return %
81.371
1Y Return %
16.771
% Away 52W High
27.612
% Away 52W Low
129.490
Daily Volume
12000
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 30/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Dr Lalchandani Labs Ltd is expected to face resistance around the 200-day EMA, with potential support at recent lows. A breakout above resistance could lead to a price increase, while a drop below support may indicate further declines.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
R
Rajasthan Petro Synthetics Ltd
Rajasthan Petro Synthetics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment. Caution is advised for new investments.
View details
L
Lyons Corporate Market Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Nippon India ETF Hang Seng BeES
The Nippon India ETF Hang Seng BeES presents a decent investment opportunity with exposure to a future-ready sector, though some risks and governance concerns exist.
View details
S
Shree Manufacturing Co Ltd
Shree Manufacturing Co Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
R
Raama Paper Mills Ltd
Raama Paper Mills Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
R
RO Jewels Ltd
RO Jewels Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
M
Motilal Oswal Nasdaq Q50 ETF
The Motilal Oswal Nasdaq Q50 ETF presents a decent investment opportunity with exposure to high-growth sectors, though investors should be cautious of market volatility and execution risks.
View details
S
Shanti Overseas (India) Ltd
Shanti Overseas shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
R
Risa International Ltd
Risa International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Milestone Global Ltd
Milestone Global Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Amraworld Agrico Ltd
Amraworld Agrico Ltd shows potential in a growing sector, but faces significant risks and challenges that could hinder performance.
View details
F
Falcon Technoprojects India Ltd
Falcon Technoprojects India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rite Zone Chemcon India Ltd
Rite Zone Chemcon India Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
G
GTN Textiles Ltd
GTN Textiles Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
G
Gleam Fabmat Ltd
Gleam Fabmat Ltd shows potential in a growing sector, but faces challenges in consistency and execution.
View details
Business Overview
Dr Lalchandani Labs Ltd is a leading diagnostic laboratory in India, dedicated to providing accurate and timely medical testing services. Catering to patients, healthcare providers, and corporate clients, the lab ensures high-quality diagnostics that empower informed health decisions. With a focus on innovation and technology, Dr Lalchandani Labs plays a crucial role in enhancing healthcare outcomes across the nation.
- Established leader in diagnostic services
- Wide range of accurate medical tests
- State-of-the-art technology and equipment
- Commitment to patient-centric care
- Trusted by healthcare professionals and patients
- Contributing to improved health outcomes in India
Investment Thesis
Dr Lalchandani Labs Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and value creation in the healthcare sector.
- Strong promoter group with a proven track record in healthcare.
- Robust growth potential in digital services, catering to evolving consumer needs.
- Attractive valuation metrics compared to industry peers, enhancing investment appeal.
- Commitment to innovation and quality, bolstering market position.
- Expanding network and service offerings, poised for long-term growth.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into tier-2 cities
- Strong brand recognition
- Innovative diagnostic services
- Partnerships with hospitals
Risks ⚠️
- Regulatory changes in healthcare
- Intense competition in diagnostics
- Economic downturn affecting spending
- Dependence on key personnel
- Technological disruptions in testing
Peer Perspective
Dr Lalchandani Labs Ltd trades at a 15% discount to peers like Metropolis and Thyrocare, primarily due to margin pressures. A focus on stabilizing margins could trigger a rerating in the coming quarters.
Future Outlook
Dr Lalchandani Labs Ltd is well-positioned for growth, driven by expanding services and market demand. Successful execution of strategic initiatives and effective cost control will be crucial to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Dr Lalchandani Labs Ltd do?A: Dr Lalchandani Labs Ltd is involved in diagnostic and healthcare services across India.
- Q: Is Dr Lalchandani Labs Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
- Q: How can I buy shares of Dr Lalchandani Labs Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about this stock?A: Check financial news websites, the company's official site, and stock market apps for updates.
📊 Stock Investment Checklist (100 Points)
Dr Lalchandani Labs Ltd • Updated: 2025-09-17 01:54:15
-
10BusinessHighThe healthcare sector is growing, but the company lacks a strong competitive moat.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow is not consistently strong.
-
8ValuationHighValuation metrics are above industry averages, indicating potential overvaluation.
-
7BalanceHighThe balance sheet shows moderate debt levels but adequate liquidity.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about transparency.
-
5DriversGoodLimited growth catalysts identified, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity affecting price action.
Final Score & Verdict
Score 68 / 100
• Decent
Dr Lalchandani Labs Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100